The OPTIMISE Study

NCT05716945 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Pseudophakic Bullous Keratopathy
Fuchs' Endothelial Dystrophy
Intraocular Pressure

Interventions

DRUG: Fluorometholone 0.1% Oph Susp
DRUG: Dexamethasone 0.1% ophthalmic suspension
OTHER: Stop steroids

Sponsor

Maastricht University Medical Center